基本信息
views: 8
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
His primary clinical interests are in urologic cancers, and his primary research interests are in cancer immunology and the biology of urologic cancers. Prof Davis is a member of the Medical & Scientific Committee and of the Standing Subcommittee on Research for the Cancer Council Victoria. He founded the Urologic Oncology Group of the Clinical Oncology Society of Australia (COSA), is a member of COSA Council, and previously a COSA Board director. Prof Davis is founder of the Australian and New Zealand Urogenital and Prostate Cancer Trials Group Ltd (ANZUP). He is chair of the ANZUP Board and of its Scientific Advisory Committee. Prof Davis has published over 250 papers with over 15,000 citations, attracted over $30M in grant funding, and been involved in over 200 clinical trials for which he was global or site Principal Investigator in over 120.
Research Interests
Papers共 465 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
European Urology Oncology (2024)
The Lancet Oncology (2024)
LANCET ONCOLOGYno. 1 (2024): 99-107
LANCET ONCOLOGYno. 1 (2024): 29-45
Matthew J. Roberts,Ciara Conduit,Ian D. Davis, Rachel M. Effeney,Scott Williams,Jarad M. Martin,Michael S. Hofman,George Hruby,Renu Eapen, Chris Gianacas,Nathan Papa,Richard De Abreu Lourenco,
BJU INTERNATIONAL (2024): 39-47
The Lancet Oncologyno. 1 (2024): 46-61
The Lancet. Oncologyno. 5 (2024): 563-571
European urology (2024)
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn